EUVIMEDEUVIMED entdecken
Crossref

How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?

Kai Huang, Maria Dufresne, Mizba Baksh, Samuel Nussbaum, Ali Abbaszadeh Kasbi, Ashary Mohammed, Pooja Advani, Andrey Morozov, Sanjay Bagaria, Sarah McLaughlin, Emmanuel Gabriel

The American Surgeon™ · 2023

DOI: 10.1177/00031348231156776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2023. Verfasst von Kai Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Triple Negative Breast Neoplasms, Carcinoma, Ductal, Breast. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Contiguous non-mass enhancement (NME) often coexists with a solid tumor component on MRI, but it can be challenging to predict whether NME represents invasive breast cancer, ductal carcinoma in situ (DCIS), benign disease, or biopsy site reaction. The purpose of this study was to determine the association between the size/extent of NME and the presence of invasive cancer and/or DCIS on final pathology.

Methods

This was a single institution retrospective analysis of a prospectively maintained breast cancer registry (2010-2020). Female patients who underwent surgical resection were included if they had a diagnosis of invasive breast cancer (with or without DCIS) and had an MRI showing both a solid mass and contiguous NME. The size of NME on MRI was compared with the size of invasive cancer and/or DCIS on the final pathology.

Results

From a total of 3443 patients, 225 patients were included. 86.2% had invasive ductal carcinoma (IDC), and 12.0% had invasive lobular carcinoma 76.9% were ER+, 16.4% were HER2+, and 13.3% were triple negative breast cancer (TNBC). 18.7% received neoadjuvant chemotherapy (NCT) of whom 31% achieved a complete radiographic/pathologic response. Pearson correlation coefficients (r) between the size of NME and invasive cancer/DCIS showed a strong and positive correlation of MRI NME with DCIS on pathology in patients without NCT. Subgroup analysis showed the strongest correlations for NME and DCIS among non-white (r = .70) and HER2 + patients (r = .74) who did not receive NCT.

Conclusions

Strong correlations between NME and DCIS were found for HER2 + disease and non-white patients, but only modest correlations were found for other patient/disease characteristics. These correlations may impact decisions in surgical approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Intraductal, NoninfiltratingBreast NeoplasmsTriple Negative Breast NeoplasmsCarcinoma, Ductal, BreastHumansFemaleRetrospective StudiesBreastCorrelation of DataPathologic Complete Response

Stichwörter der Autor:innen

breast cancerductal carcinoma in situnon-mass enhancement

Autor:innen und Institutionen

  • Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Department of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Department of Radiology, Mayo Clinic Florida, Jacksonville, FL, USA.

Zitieren

APA

Huang, K., Dufresne, M., Baksh, M., Nussbaum, S., Abbaszadeh Kasbi, A., Mohammed, A., Advani, P., Morozov, A., Bagaria, S., McLaughlin, S., & Gabriel, E. (2023). How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?. The American Surgeon™. https://doi.org/10.1177/00031348231156776

Vancouver

Huang K, Dufresne M, Baksh M, Nussbaum S, Abbaszadeh Kasbi A, Mohammed A, et al. How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?. The American Surgeon™. 2023. doi:10.1177/00031348231156776

BibTeX
@article{Huang2023,
  author = {Huang, Kai and Dufresne, Maria and Baksh, Mizba and Nussbaum, Samuel and Abbaszadeh Kasbi, Ali and Mohammed, Ashary and Advani, Pooja and Morozov, Andrey and Bagaria, Sanjay and McLaughlin, Sarah and Gabriel, Emmanuel},
  title = {How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer?},
  journal = {The American Surgeon™},
  year = {2023},
  doi = {10.1177/00031348231156776}
}
Kostenlos starten →